Sunita Crittenden, MD
Dermatology · Oklahoma City, OKNPI 1528200193
Payments from drug & device makers
Across 738 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Novartis$1K
- Johnson & Johnson$1K
- AbbVie$1K
- Pfizer$1K
- UCB, Inc.$1K
- plus $6K from 27 others
What the payments were for
- Food & beverage$13,15898%
- Education$2852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 78 | $1,375 |
| Novartis | 89 | $1,327 |
| Johnson & Johnson | 62 | $1,252 |
| AbbVie | 74 | $1,221 |
| Pfizer | 65 | $1,142 |
| UCB, Inc. | 49 | $1,055 |
| Sanofi | 37 | $930 |
| LEO Pharma Inc. | 50 | $858 |
| Regeneron Healthcare Solutions, Inc. | 25 | $683 |
| Sun Pharmaceutical Industries Inc. | 28 | $631 |
| Amgen | 35 | $617 |
| E.r. Squibb & Sons, L.L.C. | 22 | $430 |
| Arcutis Biotherapeutics, Inc. | 22 | $397 |
| Galderma Laboratories, L.p. | 28 | $363 |
| Incyte Corporation | 12 | $229 |
| Mayne Pharma Commercial LLC | 17 | $198 |
| Genentech USA, Inc. | 6 | $88 |
| Biofrontera Inc. | 5 | $81 |
| Verrica Pharmaceuticals Inc. | 3 | $72 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $68 |
| DUSA Pharmaceuticals, Inc. | 3 | $56 |
| Krystal Biotech Inc | 3 | $53 |
| Journey Medical Corporation | 3 | $46 |
| Prugen, Inc. Pharmaceuticals | 3 | $45 |
| VYNE Pharmaceuticals Inc. | 3 | $45 |
| Dermira, Inc. | 3 | $40 |
| Bristol Myers Squibb | 2 | $35 |
| Organon | 2 | $28 |
| Promius Pharma LLC | 1 | $20 |
| Nabriva Therapeutics, PLC | 1 | $18 |
| Sandoz | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,443 in reported general payments places this provider in the 80th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 17 | $231,378 |
| Dupixent SyringeDupilumab | 15 | $81,737 |
| Dupixent PenDupilumab | 15 | $55,144 |
| Fluorouracil | 27 | $1,856 |
| Clobetasol Propionate | 50 | $1,714 |
| Betamethasone Dipropionate | 36 | $1,245 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 64 | $1,204 |
| Metronidazole | 16 | $1,184 |
| Finasteride | 89 | $994 |
| Ketoconazole | 59 | $860 |
| Doxycycline Hyclate | 45 | $739 |
| Triamcinolone Acetonide | 80 | $608 |
| Dutasteride | 24 | $470 |
| Hydroxychloroquine Sulfate | 12 | $467 |
| Mupirocin | 51 | $447 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Oklahoma City
- Jarad LevinOklahoma City$1.2M
- Yaohan LamOklahoma City$1.1M
- Julie Bowman LoweOklahoma City$227K
- Kimberly JerdanOklahoma City$59K
- Mark DawkinsOklahoma City$56K
- Stacie RougasOklahoma City$50K
- Clifford HendersonOklahoma City$45K
- Quy PhamOklahoma City$14K
- Tiffany BrazealOklahoma City$13K
- Robert LehrOklahoma City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.